title: [Research progress of in vitro and in vivo anti-tumor effects and formulation of bufalin].
abstract: Bufalin is an active compound of the traditional Chinese medicine Chansu, which exhibits significant anti-tumor activities in many solid tumors and leukemia cell lines. Bufalin could introduce apoptosis, reverse drug-resistance, and prevent migration and invasion of tumor cells. This paper reviewed the latest research progress of the in vitro and in vivo anti-tumor effect and mechanism of bufalin on a series of cancers, such as hepatocellular carcinoma, lung cancer, colon cancer, gastric cancer, leukemia, bladder cancer, and its formulation study is also summarized for the reference of its further study and application.
authors.forename: Ying
authors.initials: Y
authors.lastname: Xu
authors.forename: Mei
authors.initials: M
authors.lastname: Chen
authors.forename: Xue-Feng
authors.initials: XF
authors.lastname: Jin
authors.forename: Chen
authors.initials: C
authors.lastname: Qian
authors.forename: Xi-Ming
authors.initials: XM
authors.lastname: Xu
authors.forename: Xuan
authors.initials: X
authors.lastname: Zhang
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use; D002018:Bufanolides / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D002018:Bufanolides; C022777:bufalin